The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.

Albertson, Timothy E; Chenoweth, James A; Lewis, Justin C; Pugashetti, Janelle V; Sandrock, Christian E; Morrissey, Brian M

Albertson, Timothy E; Chenoweth, James A; Lewis, Justin C; Pugashetti, Janelle V; Sandrock, Christian E; Morrissey, Brian M.

Affiliation

Albertson TE; Department of Internal Medicine, University of California, Sacramento, CA, USA.
Chenoweth JA; Department of Emergency Medicine, University of California, Sacramento, CA, USA.
Lewis JC; Department of Medicine, Va Northern California Health System, Mather, CA, USA.
Pugashetti JV; Department of Clinical Pharmacy, University of California, San Francisco, CA, USA.
Sandrock CE; Department of Emergency Medicine, University of California, Sacramento, CA, USA.
Morrissey BM; Department of Medicine, Va Northern California Health System, Mather, CA, USA.

Expert Rev Clin Pharmacol ; 15(8): 959-976, 2022 Aug.

Article de En | MEDLINE | ID: mdl-35920615

Sujet(s)
Mots clés

Vasodilatory shock; angiotensin II; corticosteroids; hydrocobalamin; methylene blue; norepinephrine; vasoplegic shock; vasopressin

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Choc / Choc septique / Infections à cytomégalovirus Type d'étude: Clinical_trials / Guideline Limites: Humans Langue: En Journal: Expert Rev Clin Pharmacol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google